Journal Article10.1097/00005053-198001000-00006
An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.
3.2K
TL;DR: The use of the ASI is suggested to match patients with treatments and to promote greater comparability of research findings, suggesting the treatment problems of patients are not necessarily related to the severity of their chemical abuse.
read more
Abstract: The Addiction Severity Index (ASI) is a structured clinical interview developed to fill the need for a reliable, valid, and standardized diagnostic and evaluative instrument in the field of alcohol and drug abuse. The ASI may be administered by a technician in 20 to 30 minutes producing 10-point problem severity ratings in each of six areas commonly affected by addiction. Analyses of these problem severity ratings on 524 male veteran alcoholics and drug addicts showed them to be highly reliable and valid. Correlational analyses using the severity ratings indicated considerable independence between the problem areas, suggesting that the treatment problems of patients are not necessarily related to the severity of their chemical abuse. Cluster analyses using these ratings revealed the presence of six subgroups having distinctly different patterns of treatment problems. The authors suggest the use of the ASI to match patients with treatments and to promote greater comparability of research findings.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males
TL;DR: Treatment strategies that increase D2Rs may, therefore, be an interesting approach to prevent relapse in opiate addiction.
104
Uses of Diverted Methadone and Buprenorphine by Opioid-Addicted Individuals in Baltimore, Maryland
Shannon Gwin Mitchell,Sharon M. Kelly,Barry S. Brown,Heather Schacht Reisinger,James Peterson,Adrienne Ruhf,Michael Agar,Kevin E. O'Grady,Robert P. Schwartz +8 more
TL;DR: The group reporting lifetime use of diverted methadone as compared to the group that did not report such use was less likely to use heroin and cocaine in the 30 days prior to admission and had lower ASI Drug Composite scores.
Pharmacotherapy of Schizophrenia Patients With Comorbid Substance Abuse
TL;DR: New generations of neuroleptics with serotonin (5-HT2) receptor antagonism and/or 5-HT1A agonist activity may reduce substance abuse in schizophrenia patients who self-medicate negative symptoms or neuroleptic side effects.
103
Reliability and validity of the German version of the European Addiction Severity Index (EuropASI).
Armin Scheurich,Matthias J. Müller,Hermann Wetzel,Ion Anghelescu,Christoph Klawe,A. Ruppe,B. Lörch,Hubertus Himmerich,M Heidenreich,G Schmid,M Hautzinger,Armin Szegedi +11 more
TL;DR: The German version of the European Addiction Severity Index presented evidence of acceptable psychometric properties and its applicability in German-speaking countries could be confirmed.
103
Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study.
James R. McKay,Helen M. Pettinati,Rebecca Morrison,Michael Feeley,Francis D. Mulvaney,Robert Gallop +5 more
TL;DR: Cocaine outcomes in depressed patients deteriorated to a greater degree after treatment than did cocaine outcomes in patients without depression, particularly in patients in RP who had a current depressive disorder at baseline.
103